English
简体中文
Total: £ 56.28
Published Date: 2026-02-06 | Pages: 118 | Tables: 115 | Medical Care
The global Pruritus Therapeutics market was valued at US$ 15320 million in 2025 and is anticipated to reach US$ 20080 million by 2032, at a CAGR of 4.0% from 2026 to 2032.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.
This report delivers a comprehensive overview of the global Pruritus Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pruritus Therapeutics. The Pruritus Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pruritus Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pruritus Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Segment by Type
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Segment by Application
External Use
Oral
Injection
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pruritus Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pruritus Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Calcineurin Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pruritus Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pruritus Therapeutics Market Perspective (2021–2032)
2.2 Global Pruritus Therapeutics Growth Trends by Region
2.2.1 Global Pruritus Therapeutics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pruritus Therapeutics Historic Market Size by Region (2021–2026)
2.2.3 Pruritus Therapeutics Forecasted Market Size by Region (2027–2032)
2.3 Pruritus Therapeutics Market Dynamics
2.3.1 Pruritus Therapeutics Industry Trends
2.3.2 Pruritus Therapeutics Market Drivers
2.3.3 Pruritus Therapeutics Market Challenges
2.3.4 Pruritus Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pruritus Therapeutics Players by Revenue
3.1.1 Global Top Pruritus Therapeutics Players by Revenue (2021–2026)
3.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2021–2026)
3.2 Global Top Pruritus Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pruritus Therapeutics Revenue
3.4 Global Pruritus Therapeutics Market Concentration Ratio
3.4.1 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pruritus Therapeutics Revenue in 2025
3.5 Global Key Players of Pruritus Therapeutics Head Offices and Areas Served
3.6 Global Key Players of Pruritus Therapeutics, Products and Applications
3.7 Global Key Players of Pruritus Therapeutics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pruritus Therapeutics Breakdown Data by Type
4.1 Global Pruritus Therapeutics Historic Market Size by Type (2021–2026)
4.2 Global Pruritus Therapeutics Forecasted Market Size by Type (2027–2032)
5 Pruritus Therapeutics Breakdown Data by Application
5.1 Global Pruritus Therapeutics Historic Market Size by Application (2021–2026)
5.2 Global Pruritus Therapeutics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pruritus Therapeutics Market Size (2021–2032)
6.2 North America Pruritus Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pruritus Therapeutics Market Size by Country (2021–2026)
6.4 North America Pruritus Therapeutics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pruritus Therapeutics Market Size (2021–2032)
7.2 Europe Pruritus Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pruritus Therapeutics Market Size by Country (2021–2026)
7.4 Europe Pruritus Therapeutics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pruritus Therapeutics Market Size (2021–2032)
8.2 Asia-Pacific Pruritus Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pruritus Therapeutics Market Size by Region (2021–2026)
8.4 Asia-Pacific Pruritus Therapeutics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pruritus Therapeutics Market Size (2021–2032)
9.2 Latin America Pruritus Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pruritus Therapeutics Market Size by Country (2021–2026)
9.4 Latin America Pruritus Therapeutics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pruritus Therapeutics Market Size (2021–2032)
10.2 Middle East & Africa Pruritus Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pruritus Therapeutics Market Size by Country (2021–2026)
10.4 Middle East & Africa Pruritus Therapeutics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 J&J
11.1.1 J&J Company Details
11.1.2 J&J Business Overview
11.1.3 J&J Pruritus Therapeutics Introduction
11.1.4 J&J Revenue in Pruritus Therapeutics Business (2021–2026)
11.1.5 J&J Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Pruritus Therapeutics Introduction
11.2.4 Abbott Revenue in Pruritus Therapeutics Business (2021–2026)
11.2.5 Abbott Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Pruritus Therapeutics Introduction
11.3.4 Amgen Revenue in Pruritus Therapeutics Business (2021–2026)
11.3.5 Amgen Recent Development
11.4 LEO Pharma
11.4.1 LEO Pharma Company Details
11.4.2 LEO Pharma Business Overview
11.4.3 LEO Pharma Pruritus Therapeutics Introduction
11.4.4 LEO Pharma Revenue in Pruritus Therapeutics Business (2021–2026)
11.4.5 LEO Pharma Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Pruritus Therapeutics Introduction
11.5.4 Novartis Revenue in Pruritus Therapeutics Business (2021–2026)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Pruritus Therapeutics Introduction
11.6.4 Bayer Revenue in Pruritus Therapeutics Business (2021–2026)
11.6.5 Bayer Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Pruritus Therapeutics Introduction
11.7.4 Pfizer Revenue in Pruritus Therapeutics Business (2021–2026)
11.7.5 Pfizer Recent Development
11.8 UCB Pharma
11.8.1 UCB Pharma Company Details
11.8.2 UCB Pharma Business Overview
11.8.3 UCB Pharma Pruritus Therapeutics Introduction
11.8.4 UCB Pharma Revenue in Pruritus Therapeutics Business (2021–2026)
11.8.5 UCB Pharma Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Pruritus Therapeutics Introduction
11.9.4 GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2021–2026)
11.9.5 GlaxoSmithKline Recent Development
11.10 Galderma
11.10.1 Galderma Company Details
11.10.2 Galderma Business Overview
11.10.3 Galderma Pruritus Therapeutics Introduction
11.10.4 Galderma Revenue in Pruritus Therapeutics Business (2021–2026)
11.10.5 Galderma Recent Development
11.11 Huapont
11.11.1 Huapont Company Details
11.11.2 Huapont Business Overview
11.11.3 Huapont Pruritus Therapeutics Introduction
11.11.4 Huapont Revenue in Pruritus Therapeutics Business (2021–2026)
11.11.5 Huapont Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Antihistamines
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Calcineurin Inhibitors
Table 5. Key Players of Others
Table 6. Global Pruritus Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Pruritus Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Pruritus Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 9. Global Pruritus Therapeutics Market Share by Region (2021–2026)
Table 10. Global Pruritus Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Pruritus Therapeutics Market Share by Region (2027–2032)
Table 12. Pruritus Therapeutics Market Trends
Table 13. Pruritus Therapeutics Market Drivers
Table 14. Pruritus Therapeutics Market Challenges
Table 15. Pruritus Therapeutics Market Restraints
Table 16. Global Pruritus Therapeutics Revenue by Players (US$ Million), 2021–2026
Table 17. Global Pruritus Therapeutics Market Share by Players (2021–2026)
Table 18. Global Top Pruritus Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pruritus Therapeutics Revenue, 2025
Table 19. Ranking of Global Top Pruritus Therapeutics Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Pruritus Therapeutics Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Pruritus Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Pruritus Therapeutics, Products and Applications
Table 23. Global Key Players of Pruritus Therapeutics, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Pruritus Therapeutics Market Size by Type (US$ Million), 2021–2026
Table 26. Global Pruritus Therapeutics Revenue Market Share by Type (2021–2026)
Table 27. Global Pruritus Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Pruritus Therapeutics Revenue Market Share by Type (2027–2032)
Table 29. Global Pruritus Therapeutics Market Size by Application (US$ Million), 2021–2026
Table 30. Global Pruritus Therapeutics Revenue Market Share by Application (2021–2026)
Table 31. Global Pruritus Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Pruritus Therapeutics Revenue Market Share by Application (2027–2032)
Table 33. North America Pruritus Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Pruritus Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 35. North America Pruritus Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Pruritus Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Pruritus Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Pruritus Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Pruritus Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Pruritus Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Pruritus Therapeutics Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Pruritus Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Pruritus Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Pruritus Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Pruritus Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Pruritus Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Pruritus Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 48. J&J Company Details
Table 49. J&J Business Overview
Table 50. J&J Pruritus Therapeutics Product
Table 51. J&J Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 52. J&J Recent Development
Table 53. Abbott Company Details
Table 54. Abbott Business Overview
Table 55. Abbott Pruritus Therapeutics Product
Table 56. Abbott Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 57. Abbott Recent Development
Table 58. Amgen Company Details
Table 59. Amgen Business Overview
Table 60. Amgen Pruritus Therapeutics Product
Table 61. Amgen Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 62. Amgen Recent Development
Table 63. LEO Pharma Company Details
Table 64. LEO Pharma Business Overview
Table 65. LEO Pharma Pruritus Therapeutics Product
Table 66. LEO Pharma Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 67. LEO Pharma Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Pruritus Therapeutics Product
Table 71. Novartis Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 72. Novartis Recent Development
Table 73. Bayer Company Details
Table 74. Bayer Business Overview
Table 75. Bayer Pruritus Therapeutics Product
Table 76. Bayer Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 77. Bayer Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Pruritus Therapeutics Product
Table 81. Pfizer Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 82. Pfizer Recent Development
Table 83. UCB Pharma Company Details
Table 84. UCB Pharma Business Overview
Table 85. UCB Pharma Pruritus Therapeutics Product
Table 86. UCB Pharma Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 87. UCB Pharma Recent Development
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Pruritus Therapeutics Product
Table 91. GlaxoSmithKline Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 92. GlaxoSmithKline Recent Development
Table 93. Galderma Company Details
Table 94. Galderma Business Overview
Table 95. Galderma Pruritus Therapeutics Product
Table 96. Galderma Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 97. Galderma Recent Development
Table 98. Huapont Company Details
Table 99. Huapont Business Overview
Table 100. Huapont Pruritus Therapeutics Product
Table 101. Huapont Revenue in Pruritus Therapeutics Business (US$ Million), 2021–2026
Table 102. Huapont Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Pruritus Therapeutics Picture
Figure 2. Global Pruritus Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Pruritus Therapeutics Market Share by Type: 2025 vs 2032
Figure 4. Antihistamines Features
Figure 5. Corticosteroids Features
Figure 6. Calcineurin Inhibitors Features
Figure 7. Others Features
Figure 8. Global Pruritus Therapeutics Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Pruritus Therapeutics Market Share by Application: 2025 vs 2032
Figure 10. External Use Case Studies
Figure 11. Oral Case Studies
Figure 12. Injection Case Studies
Figure 13. Pruritus Therapeutics Report Years Considered
Figure 14. Global Pruritus Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Pruritus Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Pruritus Therapeutics Market Share by Region: 2025 vs 2032
Figure 17. Global Pruritus Therapeutics Market Share by Players in 2025
Figure 18. Global Pruritus Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Pruritus Therapeutics Revenue in 2025
Figure 20. North America Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Pruritus Therapeutics Market Share by Country (2021–2032)
Figure 22. United States Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Pruritus Therapeutics Market Share by Country (2021–2032)
Figure 26. Germany Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Pruritus Therapeutics Market Share by Region (2021–2032)
Figure 34. China Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Pruritus Therapeutics Market Share by Country (2021–2032)
Figure 42. Mexico Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Pruritus Therapeutics Market Share by Country (2021–2032)
Figure 46. Israel Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Pruritus Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. J&J Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 50. Abbott Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 51. Amgen Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 52. LEO Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 53. Novartis Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 54. Bayer Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 55. Pfizer Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 56. UCB Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 58. Galderma Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 59. Huapont Revenue Growth Rate in Pruritus Therapeutics Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
